Astera Labs, Inc. (NASDAQ:ALAB) Shares Sold by TD Waterhouse Canada Inc.

TD Waterhouse Canada Inc. decreased its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 31.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 70,184 shares of the company’s stock after selling 32,530 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in Astera Labs were worth $9,295,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of ALAB. Whittier Trust Co. of Nevada Inc. purchased a new stake in shares of Astera Labs during the fourth quarter worth approximately $25,000. Steward Partners Investment Advisory LLC raised its holdings in shares of Astera Labs by 99.0% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company’s stock valued at $26,000 after purchasing an additional 99 shares in the last quarter. Kestra Investment Management LLC purchased a new stake in shares of Astera Labs during the 4th quarter worth $28,000. Geneos Wealth Management Inc. acquired a new position in shares of Astera Labs during the fourth quarter worth $36,000. Finally, Global Retirement Partners LLC increased its holdings in Astera Labs by 3,155.6% in the fourth quarter. Global Retirement Partners LLC now owns 293 shares of the company’s stock valued at $39,000 after buying an additional 284 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Wall Street Analysts Forecast Growth

ALAB has been the subject of several analyst reports. Stifel Nicolaus lowered their price objective on Astera Labs from $150.00 to $100.00 and set a “buy” rating for the company in a research report on Thursday, April 17th. Citigroup lowered their price target on Astera Labs from $120.00 to $100.00 and set a “buy” rating for the company in a report on Monday, April 14th. Raymond James started coverage on shares of Astera Labs in a report on Friday, March 14th. They set an “outperform” rating and a $82.00 price objective on the stock. Barclays increased their target price on shares of Astera Labs from $87.00 to $135.00 and gave the company an “overweight” rating in a research report on Friday, January 17th. Finally, Morgan Stanley decreased their price objective on shares of Astera Labs from $142.00 to $114.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 28th. One analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Astera Labs has an average rating of “Buy” and an average price target of $109.25.

Astera Labs Trading Down 7.7 %

Shares of ALAB stock opened at $54.42 on Tuesday. Astera Labs, Inc. has a twelve month low of $36.22 and a twelve month high of $147.39. The business’s 50 day moving average is $68.57 and its two-hundred day moving average is $91.44. The company has a market capitalization of $8.82 billion and a P/E ratio of -31.46.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.16). Astera Labs had a negative return on equity of 10.40% and a negative net margin of 21.05%. As a group, equities analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Activity at Astera Labs

In other Astera Labs news, Director Michael E. Hurlston sold 2,500 shares of the firm’s stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $92.08, for a total value of $230,200.00. Following the completion of the sale, the director now owns 91,794 shares of the company’s stock, valued at approximately $8,452,391.52. This trade represents a 2.65 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, General Counsel Philip Mazzara sold 7,536 shares of the stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $92.07, for a total transaction of $693,839.52. Following the completion of the transaction, the general counsel now owns 241,209 shares of the company’s stock, valued at $22,208,112.63. This represents a 3.03 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 633,990 shares of company stock worth $54,235,012 over the last 90 days.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.